
Gelteq Limited Ordinary Shares
Gelteq Limited Ordinary Shares (GELS) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001920092 · GELS · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001920092 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Gelteq Limited Ordinary Shares (NASDAQ: GELS) has submitted 69 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2024. As a Healthcare sector company with CIK 0001920092, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Gelteq Limited Ordinary Shares's most comprehensive regulatory disclosure. The most recent Gelteq Limited Ordinary Shares 10-K was filed on 2025-11-17 for fiscal year ending 2025. Historical GELS 10-K annual reports are available from 2022 through 2025.
Investors researching Gelteq Limited Ordinary Shares SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
GELS SEC Filings · 8 questionsGelteq Limited Ordinary Shares (GELS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 69 filings and access original documents at no cost. Gelteq Limited Ordinary Shares's CIK is 0001920092.